Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Patent Expiration

Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate is Used for cleansing the colon as preparation for colonoscopy in adults. It was first introduced by Braintree Laboratories Inc in its drug Suprep Bowel Prep Kit on Aug 5, 2010. Another drug containing Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate is Colprep Kit. 9 different companies have introduced drugs containing Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate.


Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Patents

Given below is the list of patents protecting Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Suprep Bowel Prep Kit US6946149 Salt solution for colon cleansing Mar 07, 2023

(Expired)

Braintree Labs



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate's patents.

Given below is the list recent legal activities going on the following patents of Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA) 01 Jul, 2021 US6946149(Litigated)
Correspondence Address Change 30 Jun, 2021 US6946149(Litigated)
Second letter to regulating agency to determine regulatory review period 26 Jul, 2016 US6946149(Litigated)
Mail-Petition Decision - Granted 19 Mar, 2015 US6946149(Litigated)
Notice of Final Determination- Ineligible 18 Mar, 2015 US6946149(Litigated)
Petition Decision - Granted 18 Mar, 2015 US6946149(Litigated)
Petition Entered 02 May, 2011 US6946149(Litigated)
Patent Term Extension Application under 35 USC 156 Filed 02 May, 2011 US6946149(Litigated)
Letter from FDA or Dept of Agriculture re PTE application 27 Apr, 2011 US6946149(Litigated)
Initial letter Re: PTE Application to regulating agency 21 Jan, 2011 US6946149(Litigated)


Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Generic API Manufacturers

Several generic applications have been filed for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. The first generic version for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate was by Novel Laboratories Inc and was approved on Feb 23, 2017. And the latest generic version is by Annora Pharma Private Ltd and was approved on Oct 18, 2024.

Given below is the list of companies who have filed for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate generic, along with the locations of their manufacturing plants worldwide.